Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours

Shaan M. Raza, Gustavo Pradilla, Federico G. Legnani, Quoc Anh Thai, Alessandro Olivi, Jon D. Weingart, Henry Brem

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recent advances in the treatment of malignant brain tumours have focused on the development of targeted local delivery of therapeutic agents, which combine various antineoplastic strategies that include cytotoxic, antiangiogenic and immunomodulatory mechanisms, among others. The introduction of local delivery devices for sustained administration of antineoplastic agents represents a new opportunity to effectively treat these malignancies by facilitating the intracranial administration of safe and clinically efficacious doses for prolonged periods of time in a controlled fashion. This technology circumvents the need for high systemic doses with potentially harmful toxicities, bypasses the blood-brain barrier and can be tailored to deliver new agents with complex pharmacological properties. Based on local delivery strategies, new delivery systems, including convection-enhanced delivery and microchips, have been developed. As a result, recent advances in tumour biology have been adopted as potentially translatable treatments and are undergoing preclinical and clinical evaluation at present. These novel approaches could improve the prognosis of patients with these tumours.

Original languageEnglish
Pages (from-to)477-494
Number of pages18
JournalExpert Opinion on Biological Therapy
Volume5
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Brain Neoplasms
Antineoplastic Agents
Tumors
Brain
Polymers
Neoplasms
Convection
Blood-Brain Barrier
Toxicity
Therapeutics
Pharmacology
Technology
Equipment and Supplies

Keywords

  • Angiogenesis
  • Brain tumour
  • Controlled-release polymers
  • Convection-enhanced delivery
  • Glioblastoma multiforme
  • Immunotherapy
  • Local delivery
  • Microchip

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours. / Raza, Shaan M.; Pradilla, Gustavo; Legnani, Federico G.; Thai, Quoc Anh; Olivi, Alessandro; Weingart, Jon D.; Brem, Henry.

In: Expert Opinion on Biological Therapy, Vol. 5, No. 4, 04.2005, p. 477-494.

Research output: Contribution to journalArticle

Raza, Shaan M. ; Pradilla, Gustavo ; Legnani, Federico G. ; Thai, Quoc Anh ; Olivi, Alessandro ; Weingart, Jon D. ; Brem, Henry. / Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours. In: Expert Opinion on Biological Therapy. 2005 ; Vol. 5, No. 4. pp. 477-494.
@article{3da55792399543499f487e5a623a7b85,
title = "Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours",
abstract = "Recent advances in the treatment of malignant brain tumours have focused on the development of targeted local delivery of therapeutic agents, which combine various antineoplastic strategies that include cytotoxic, antiangiogenic and immunomodulatory mechanisms, among others. The introduction of local delivery devices for sustained administration of antineoplastic agents represents a new opportunity to effectively treat these malignancies by facilitating the intracranial administration of safe and clinically efficacious doses for prolonged periods of time in a controlled fashion. This technology circumvents the need for high systemic doses with potentially harmful toxicities, bypasses the blood-brain barrier and can be tailored to deliver new agents with complex pharmacological properties. Based on local delivery strategies, new delivery systems, including convection-enhanced delivery and microchips, have been developed. As a result, recent advances in tumour biology have been adopted as potentially translatable treatments and are undergoing preclinical and clinical evaluation at present. These novel approaches could improve the prognosis of patients with these tumours.",
keywords = "Angiogenesis, Brain tumour, Controlled-release polymers, Convection-enhanced delivery, Glioblastoma multiforme, Immunotherapy, Local delivery, Microchip",
author = "Raza, {Shaan M.} and Gustavo Pradilla and Legnani, {Federico G.} and Thai, {Quoc Anh} and Alessandro Olivi and Weingart, {Jon D.} and Henry Brem",
year = "2005",
month = "4",
doi = "10.1517/14712598.5.4.477",
language = "English",
volume = "5",
pages = "477--494",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours

AU - Raza, Shaan M.

AU - Pradilla, Gustavo

AU - Legnani, Federico G.

AU - Thai, Quoc Anh

AU - Olivi, Alessandro

AU - Weingart, Jon D.

AU - Brem, Henry

PY - 2005/4

Y1 - 2005/4

N2 - Recent advances in the treatment of malignant brain tumours have focused on the development of targeted local delivery of therapeutic agents, which combine various antineoplastic strategies that include cytotoxic, antiangiogenic and immunomodulatory mechanisms, among others. The introduction of local delivery devices for sustained administration of antineoplastic agents represents a new opportunity to effectively treat these malignancies by facilitating the intracranial administration of safe and clinically efficacious doses for prolonged periods of time in a controlled fashion. This technology circumvents the need for high systemic doses with potentially harmful toxicities, bypasses the blood-brain barrier and can be tailored to deliver new agents with complex pharmacological properties. Based on local delivery strategies, new delivery systems, including convection-enhanced delivery and microchips, have been developed. As a result, recent advances in tumour biology have been adopted as potentially translatable treatments and are undergoing preclinical and clinical evaluation at present. These novel approaches could improve the prognosis of patients with these tumours.

AB - Recent advances in the treatment of malignant brain tumours have focused on the development of targeted local delivery of therapeutic agents, which combine various antineoplastic strategies that include cytotoxic, antiangiogenic and immunomodulatory mechanisms, among others. The introduction of local delivery devices for sustained administration of antineoplastic agents represents a new opportunity to effectively treat these malignancies by facilitating the intracranial administration of safe and clinically efficacious doses for prolonged periods of time in a controlled fashion. This technology circumvents the need for high systemic doses with potentially harmful toxicities, bypasses the blood-brain barrier and can be tailored to deliver new agents with complex pharmacological properties. Based on local delivery strategies, new delivery systems, including convection-enhanced delivery and microchips, have been developed. As a result, recent advances in tumour biology have been adopted as potentially translatable treatments and are undergoing preclinical and clinical evaluation at present. These novel approaches could improve the prognosis of patients with these tumours.

KW - Angiogenesis

KW - Brain tumour

KW - Controlled-release polymers

KW - Convection-enhanced delivery

KW - Glioblastoma multiforme

KW - Immunotherapy

KW - Local delivery

KW - Microchip

UR - http://www.scopus.com/inward/record.url?scp=17844380277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844380277&partnerID=8YFLogxK

U2 - 10.1517/14712598.5.4.477

DO - 10.1517/14712598.5.4.477

M3 - Article

VL - 5

SP - 477

EP - 494

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 4

ER -